FDA Adverse Event Injury Summary report: N

LAP-BAND SYSTEM

MDR report key: 20729653 · Received November 19, 2024

Report

Report Number
3013508647-2024-00069
Event Type
Injury
Date Received
November 19, 2024
Date of Event
June 7, 2024
Report Date
February 10, 2025
Manufacturer
RESHAPE LIFESCIENCES
Product Code
LTI
UDI-DI
00850007764654
PMA / PMN Number
P000008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
RISK MANAGER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

A LETTER WAS RECEIVED FROM FDA MEDWATCH PROGRAM WITH REPORT # MW5162807; THE REPORT WAS REVIEWED IT AND WAS DISCOVERED THAT THIS REPORT IS THE SAME AS THE MW515979 REPORT SENT TO APOLLO ENDOSURGERY, INC. ON (B)(6) 2024. WE CONSIDER THIS A DUPLICATE REPORT AND WILL NOT DOCUMENT IT AS A NEW COMPLAINT. CONSEQUENTLY, A NEW MDR WILL NOT BE SUBMITTED. A RESPONSE WAS SENT TO FDA WITH THE EXPLANATION IN (B)(6), 2024.

Additional Manufacturer Narrative · 0

THE REPORTED DEVICE WAS NOT AVAILABLE FOR PHYSICAL EVALUATION. THE INVESTIGATION INVOLVED COMMUNICATION VIA EMAIL WITH THE REPORTER TO CLARIFY THE DESCRIPTION OF THE EVENT, AND THE ANALYSIS OF RELEVANT INFORMATION PROVIDED IN VIEW OF SUPPORTING THE IDENTIFICATION OF POSSIBLE CAUSES FOR THE ADVERSE EVENT. THE INVESTIGATION INVOLVED THE ANALYSYS OF THE LOT HISTORY RECORDS OF THE LAP-BAND DEVICE INVOLVED. LOT HISTORY RECORD WAS REVIEWED, AND NO DISCREPANCIES OR NON-CONFORMANCE'S WERE RECORDED. THE PRODUCT WAS MANUFACTURED ACCORDING TO SPECIFICATIONS. NO NEW RISKS IDENTIFIED, THE CURRENT RISK IS IDENTIFIED WITH A LOW RATE OF OCCURRENCE FOR THE REPORTED COMPLAINT CATEGORIES. NO CORRECTION OR CORRECTIVE ACTION REQUIRED. LIMITED INVESTIGATION DOES NOT LEAD TO A CLEAR CONCLUSION ABOUT THE CAUSE OF THE REPORTED ADVERSE EVENT.

Description of Event or Problem · 0

REPORT # MW5162807 WAS RECEIVED THROUGH FDA'S MEDWATCH PROGRAM. THE REPORT RECEIVED IS A DUPLICATE OF REPORT # MW5159479. THE PATIENT PRESENTED WITH MILD EPIGASTRIC PAIN AND REFLUX AND UPPER ENDOSCOPY WAS PERFORMED, WHICH REVEALED ERODED LAP-BAND AND LAP BAND REMOVAL WAS RECOMMENDED. LAP BAND WAS FOUND PENETRATING IN THE CARDIA ON THE GREATER CURVE SIDE. NO INFLAMMATION WAS REALLY NOTED. THE SURGEON CUT THE LAP BAND INTO PIECES TO REMOVE AND ONE WAS LEFT BEHIND, WHICH THEY HAD TO GO BACK TO RETRIEVE.

Description of Event or Problem · 0

REPORT, (MW5159479) WAS RECEIVED THROUGH FDA'S MEDWATCH PROGRAM. THE PATIENT PRESENTED WITH MILD EPIGASTRIC PAIN AND REFLUX AND UPPER ENDOSCOPY WAS PERFORMED, WHICH REVEALED ERODED LAP-BAND AND LAP BAND REMOVAL WAS RECOMMENDED. LAP BAND WAS FOUND PENETRATING IN THE CARDIA ON THE GREATER CURVE SIDE. NO INFLAMMATION WAS REALLY NOTED. THE SURGEON CUT THE LAP BAND INTO PIECES TO REMOVE AND ONE WAS LEFT BEHIND, WHICH THEY HAD TO GO BACK TO RETRIEVE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2314066 LAP-BAND SYSTEM ADJUSTABLE GASTRIC BAND LTI RESHAPE LIFESCIENCES 75EA2685 00850007764654

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention